Klaria Pharma Holding AB (publ.) (STO:KLAR)

STO:KLAR Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.47	0.34	0.6	1.25	16.76	25.49
Cash & Short-Term Investments	8.47	0.34	0.6	1.25	16.76	25.49
Cash Growth	330.07%	-42.81%	-52.04%	-92.56%	-34.25%	-18.43%
Accounts Receivable	4.09	-	0.36	0.53	2.21	0.01
Other Receivables	-	0.73	0.92	1.35	1.48	1.75
Receivables	4.09	0.73	1.27	1.89	3.69	1.76
Prepaid Expenses	-	1.32	0.98	1.34	0.52	0.55
Other Current Assets	-	-	-	-	19.79	-
Total Current Assets	12.56	2.39	2.85	4.47	40.76	27.8
Property, Plant & Equipment	0.15	0.59	1.47	0.37	1.07	1.72
Other Intangible Assets	24.75	29.55	52.95	68.11	78.45	88.79
Total Assets	37.47	32.53	57.27	72.95	120.27	118.31

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	9.16	7.01	5.33	9.65	8.63
Accrued Expenses	-	9.34	21.93	6.25	6.3	7.33
Short-Term Debt	-	14.8	22.94	19.6	17.15	30.05
Current Portion of Leases	-	0.65	0.87	0.34	0.68	0.66
Current Income Taxes Payable	-	-	-	-	0	0.06
Other Current Liabilities	61.38	0.94	0.6	0.29	10.08	1.15
Total Current Liabilities	61.38	34.88	53.34	31.81	43.85	47.87
Long-Term Debt	-	9.7	-	-	-	-
Long-Term Leases	-	-	0.62	-	0.34	1.02
Total Liabilities	71.08	44.58	53.96	31.81	44.19	48.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	-33.62	4.1	2.41	1.78	1.31	0.86
Additional Paid-In Capital	-	31.12	48.77	279.07	173.06	238.44
Retained Earnings	-	-47.06	-47.75	-239.65	-98.27	-169.87
Comprehensive Income & Other	-	-0.21	-0.12	-0.06	-0.02	-0.02
Total Common Equity	-33.62	-12.05	3.31	41.13	76.08	69.41
Minority Interest	0	0	0	0	0	0
Shareholders' Equity	-33.62	-12.04	3.31	41.13	76.08	69.42
Total Liabilities & Equity	37.47	32.53	57.27	72.95	120.27	118.31

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	25.15	24.43	19.94	18.17	31.72
Net Cash (Debt)	8.47	-24.8	-23.83	-18.7	-1.4	-6.23
Net Cash Growth	526.33%	-	-	-	-	-
Net Cash Per Share	0.04	-0.13	-0.19	-0.19	-0.02	-0.12
Filing Date Shares Outstanding	245.98	245.98	144.76	106.5	106.5	51.81
Total Common Shares Outstanding	245.98	245.98	144.76	106.5	78.38	51.81
Working Capital	-48.82	-32.48	-50.49	-27.34	-3.09	-20.07
Book Value Per Share	-0.14	-0.05	0.02	0.39	0.97	1.34
Tangible Book Value	-58.37	-41.59	-49.64	-26.97	-2.37	-19.37
Tangible Book Value Per Share	-0.24	-0.17	-0.34	-0.25	-0.03	-0.37
Machinery	-	0.21	0.21	0.21	0.21	0.16

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error